Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Zika Vaccine Enters Clinical Trials

Zika Vaccine Enters Clinical Trials News & Analysis Health Agencies Update Zika Vaccine Enters Clinical Trials Response (ASPR) has awarded $5.1 million to As the first local mosquito-borne transmis- Seattle-basedInBiosInternational,Inc,forad- sions of the Zika virus are being reported in vanced development of a test that diagno- the continental United States, an investiga- ses Zika infection within 4 hours. tional vaccine developed by the National In- The current diagnostic test, developed stitute of Allergy and Infectious Diseases by the Centers for Disease Control and Pre- (NIAID) at the National Institutes of Health vention (CDC), requires 2 to 3 days for re- (NIH) is entering phase 1 clinical trials. sults and can only be conducted in CDC- At least 80 people between the ages of designated laboratories. Contrastingly, the 18 and 35 years will be enrolled in the trial, new diagnostic test could be used in com- which will take place at 3 study sites in the mercial and health care facility laborato- United States including the NIH Clinical Cen- ries, significantly expanding Zika testing. ter in Bethesda, Maryland. The trial will test “Doctors and patients need Zika test re- vaccine safety and immunogenicity. sultsquicklysothathealthcareproviderscan Scientists at NIAID’s Vaccine Research offer appropriate guidance and treatment to http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Zika Vaccine Enters Clinical Trials

JAMA , Volume 316 (12) – Sep 27, 2016

Zika Vaccine Enters Clinical Trials

Abstract

News & Analysis Health Agencies Update Zika Vaccine Enters Clinical Trials Response (ASPR) has awarded $5.1 million to As the first local mosquito-borne transmis- Seattle-basedInBiosInternational,Inc,forad- sions of the Zika virus are being reported in vanced development of a test that diagno- the continental United States, an investiga- ses Zika infection within 4 hours. tional vaccine developed by the National In- The current diagnostic test, developed stitute of Allergy and Infectious...
Loading next page...
 
/lp/american-medical-association/zika-vaccine-enters-clinical-trials-0e1DHCwlUF

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2016.12760
Publisher site
See Article on Publisher Site

Abstract

News & Analysis Health Agencies Update Zika Vaccine Enters Clinical Trials Response (ASPR) has awarded $5.1 million to As the first local mosquito-borne transmis- Seattle-basedInBiosInternational,Inc,forad- sions of the Zika virus are being reported in vanced development of a test that diagno- the continental United States, an investiga- ses Zika infection within 4 hours. tional vaccine developed by the National In- The current diagnostic test, developed stitute of Allergy and Infectious Diseases by the Centers for Disease Control and Pre- (NIAID) at the National Institutes of Health vention (CDC), requires 2 to 3 days for re- (NIH) is entering phase 1 clinical trials. sults and can only be conducted in CDC- At least 80 people between the ages of designated laboratories. Contrastingly, the 18 and 35 years will be enrolled in the trial, new diagnostic test could be used in com- which will take place at 3 study sites in the mercial and health care facility laborato- United States including the NIH Clinical Cen- ries, significantly expanding Zika testing. ter in Bethesda, Maryland. The trial will test “Doctors and patients need Zika test re- vaccine safety and immunogenicity. sultsquicklysothathealthcareproviderscan Scientists at NIAID’s Vaccine Research offer appropriate guidance and treatment to

Journal

JAMAAmerican Medical Association

Published: Sep 27, 2016

There are no references for this article.